文献速递呼吸衰竭与机械通气消化、代谢与肾脏急症

急诊科耐甲氧西林金黄色葡萄球菌鼻拭子筛查对肺炎抗MRSA治疗时长的影响

Emergency department methicillin-resistant Staphylococcus aureus nare screen effect on pneumonia treatment duration.
PubMed 文献 · Am J Emerg Med · 2021-01-28
一句话结论在急诊启动抗MRSA治疗并收入普通内科的肺炎患者中,急诊MRSA鼻拭子筛查未缩短抗MRSA抗生素使用时长(30.5 h vs 24.5 h,p=0.28)。

本研究为单中心回顾性研究,纳入116例在急诊诊断为肺炎并启动抗MRSA治疗(万古霉素或利奈唑胺)后收入普通内科的患者,分为急诊未行MRSA鼻拭子筛查组(79例)和筛查组(37例)。主要终点抗MRSA抗生素使用时长两组相似(未筛查组30.5小时[IQR 20.5-52.5] vs 筛查组24.5小时[IQR 20.6-40.3],p=0.28)。筛查组中35例阴性、2例阳性。次要终点(万古霉素谷浓度评估、住院生存、急性肾损伤)两组相似。作者认为目前急诊医生无需为收入普通内科的患者考虑急诊MRSA鼻拭子筛查,但可考虑开展更大规模研究。

要点

  • 在急诊启动抗MRSA治疗并收入普通内科的肺炎患者中,急诊MRSA鼻拭子筛查未缩短抗MRSA抗生素使用时长(未筛查组30.5小时 vs 筛查组24.5小时,p=0.28)。
  • 筛查组37例中35例鼻拭子阴性、2例阳性。
  • 次要终点万古霉素谷浓度评估、住院生存和急性肾损伤在两组间相似。
  • 作者认为目前急诊医生无需为收入普通内科的患者考虑急诊MRSA鼻拭子筛查,但可考虑开展更大规模研究。

适用人群与场景

  • 在急诊诊断为肺炎、在急诊启动抗MRSA治疗(万古霉素或利奈唑胺)并随后收入普通内科的患者。

研究设计与关键结果

  • 单中心回顾性研究,纳入116例在急诊诊断为肺炎并启动抗MRSA治疗(万古霉素或利奈唑胺)后收入普通内科的患者。
  • 分组:未在急诊行MRSA鼻拭子筛查组79例 vs 在急诊行MRSA鼻拭子筛查组37例。
  • 主要终点抗MRSA抗生素使用时长两组相似:未筛查组30.5小时(IQR 20.5-52.5) vs 筛查组24.5小时(IQR 20.6-40.3),p=0.28。
  • 筛查组37例中35例鼻拭子阴性、2例阳性。
  • 次要终点万古霉素谷浓度评估、住院生存和急性肾损伤两组相似。

证据类型、等级与局限

  • 证据类型:单中心回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对于收入普通内科的肺炎患者,急诊医生目前无需考虑在急诊进行MRSA鼻拭子筛查,但可考虑开展更大规模研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: The objective of this study was to determine if performing a methicillin-resistant Staphylococcus aureus (MRSA) nasal screen in the emergency department (ED) decreased general medicine patient exposure to anti-MRSA antibiotics for pneumonia.

METHODS: This was a single-center, retrospective study evaluating patients who had a diagnosis of pneumonia and were initiated on anti-MRSA therapy (vancomycin or linezolid) in the ED and subsequently admitted to a general medicine floor. Patients were divided into two groups: 1) did not receive a MRSA nares screen in the ED (No MRSA screen group) or 2) received a MRSA nares screen in the ED (MRSA screen group). The primary outcome was anti-MRSA antibiotic duration. Secondary outcomes included vancomycin level evaluation, hospital survival, and acute kidney injury.

RESULTS: Of the 116 patients included, 37 patients received a MRSA nares screen in the ED and 79 patients did not. Median duration of antibiotic exposure was similar for both groups (No MRSA screen, 30.5 h [interquartile range (IQR) 20.5-52.5] vs. MRSA screen, 24.5 h [IQR 20.6-40.3]; p = 0.28). Of patients who were screened, 35 were negative and 2 were positive. Secondary outcomes were similar.

CONCLUSION: Performing a MRSA nares screen in the ED for patients diagnosed with pneumonia, initiated on anti-MRSA antibiotics, and admitted to a general medicine floor did not decrease duration of anti-MRSA antibiotics. At this time, ED providers do not need to consider a MRSA nasal screen in the ED for patients being admitted to general medicine, although larger studies could be considered.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Renzoni AJ, Peksa GD, DeMott JM, et al. Emergency department methicillin-resistant Staphylococcus aureus nare screen effect on pneumonia treatment duration. Am J Emerg Med. 2021. PMID: 33581603. doi:10.1016/j.ajem.2021.01.066

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。